Extension of Time to File SOU

CERULEAN

Cerulean Pharma Inc.

Trademark/Service Extension of Time

PTO Form 1581 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 10/31/2017)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 85442528
LAW OFFICE ASSIGNED LAW OFFICE 116
MARK SECTION
MARK CERULEAN
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT CERULEAN
OWNER SECTION
NAME Cerulean Pharma Inc.
STREET 840 Memorial Drive, 5th Floor
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02139
COUNTRY United States
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION pharmaceutical preparations for use in the diagnosis, prognosis or prevention of oncological diseases or disorders, including malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations for use in the diagnosis, prognosis and prevention of oncological diseases or disorders, including malignant cancers or neoplasms, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in modulating angiogenesis, containing nanometer size compounds which facilitate targeting or delivery of the active ingredient
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 05/15/2012
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT 150
TOTAL AMOUNT 150
SIGNATURE SECTION
       ORIGINAL PDF FILE hw_6547140130-111122298_._LEAN_in_Class_5_-_Signed_Second_Extension_Request__F1222313_.PDF
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT16\IMAGEOUT16\854\425\85442528\xml8\ESU0002.JPG
        \\TICRS\EXPORT16\IMAGEOUT16\854\425\85442528\xml8\ESU0003.JPG
SIGNATORY'S NAME Jean M. Silveri
SIGNATORY'S POSITION General Counsel
FILING INFORMATION
SUBMIT DATE Tue May 07 11:16:38 EDT 2013
TEAS STAMP USPTO/ESU-XX.XX.XXX.XXX-2
0130507111638129156-85442
528-500911f28060bdbd5ac75
5e24a6912de64e28ab9ec8637
cc2b25314a186da-DA-9945-2
0130507111122298114



PTO Form 1581 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 10/31/2017)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: CERULEAN
SERIAL NUMBER: 85442528

The applicant, Cerulean Pharma Inc., having an address of
      840 Memorial Drive, 5th Floor
      Cambridge, Massachusetts 02139
      United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 05/15/2012.

For International Class 005:
Current identification: pharmaceutical preparations for use in the diagnosis, prognosis or prevention of oncological diseases or disorders, including malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations for use in the diagnosis, prognosis and prevention of oncological diseases or disorders, including malignant cancers or neoplasms, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in modulating angiogenesis, containing nanometer size compounds which facilitate targeting or delivery of the active ingredient

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development



A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.


Declaration



Original PDF file:
hw_6547140130-111122298_._LEAN_in_Class_5_-_Signed_Second_Extension_Request__F1222313_.PDF
Converted PDF file(s) (2 pages)
Signature File1
Signature File2

Signatory's Name: Jean M. Silveri
Signatory's Position: General Counsel

RAM Sale Number: 85442528
RAM Accounting Date: 05/07/2013

Serial Number: 85442528
Internet Transmission Date: Tue May 07 11:16:38 EDT 2013
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XXX-2013050711163812
9156-85442528-500911f28060bdbd5ac755e24a
6912de64e28ab9ec8637cc2b25314a186da-DA-9
945-20130507111122298114



Extension of Time to File SOU [image/jpeg]

Extension of Time to File SOU [image/jpeg]

Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed